Related content

Efficacy of chemotherapy plus gefitinib treatment in advanced nonsmallcell lung cancer patients following acquired resistance to gefitinib

By    

Molecular and Clinical Oncology, Vol. 1, Iss. 5, 2013-01 ,pp. : 875-878

Spandidos Publications

Access to resources Recommend Favorite

Rechallenge with pemetrexed-based chemotherapy improves the survival of patients with advanced non-squamous non-smallcell lung cancer

By                    

Molecular and Clinical Oncology, Vol. 2, Iss. 6, 2014-01 ,pp. : 953-959

Spandidos Publications

Access to resources Recommend Favorite

Prognostic value of peripheral and local forkhead box p3+ regulatory T cells in patients with non-smallcell lung cancer

By                    

Molecular and Clinical Oncology, Vol. 2, Iss. 5, 2014-01 ,pp. : 685-694

Spandidos Publications

Access to resources Recommend Favorite

Histological subtype and smoking status, but not gender, are associated with epidermal growth factor receptor mutations in non-smallcell lung cancer

By                      

Molecular and Clinical Oncology, Vol. 2, Iss. 2, 2014-01 ,pp. : 252-258

Spandidos Publications

Access to resources Recommend Favorite

Efficacy of tyrosine kinase inhibitors in nonsmallcell lung cancer patients undergoing dose reduction and those with a low body surface area

By                    

Molecular and Clinical Oncology, Vol. 2, Iss. 4, 2014-01 ,pp. : 604-608

Spandidos Publications

Access to resources Recommend Favorite